Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)
Public ClinicalTrials.gov record NCT01475955. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of Photodynamic Therapy With LEVULAN® Topical Solution + Blue Light Versus LEVULAN® Topical Solution Vehicle + Blue Light Using Spot and Broad Area Application and Incubation Times of 1, 2 and 3 Hours for the Treatment of Multiple Actinic Keratoses on the Face or Scalp
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if Levulan Photodynamic Therapy (PDT) is safe and effective in the treatment of actinic keratosis when applied to broad areas on the face and scalp for 1, 2 and 3 hours.
Study identification
- NCT ID
- NCT01475955
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 235 participants
Conditions and interventions
Conditions
Interventions
- Broad Area ALA 1-hour incubation Drug
- Broad Area ALA 2 hour incubation Drug
- broad area ALA 3-hour incubation Drug
- Spot ALA 2 hour incubation Drug
- Vehicle PDT Drug
- Blue Light Treatment Device
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2011 (Type not available)
- Primary completion
- Nov 2012 (Actual)
- Completion
- Nov 2012 (Actual)
- Last update posted
- Oct 28, 2016
2011 – 2012
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD Dermatology Perlman Ambulatory Clinic | La Jolla | California | 92037 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Northwest Clinical Trials, Inc. | Boise | Idaho | 83704 | — |
| Altman Dermatology Associates | Arlington Heights | Illinois | 60005 | — |
| The Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Dermatology Research Center of Cincinnati | Cincinnati | Ohio | 45220 | — |
| Oregon Medical Research Center, PC | Portland | Oregon | 97223 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
| DermResearch, Inc. | Austin | Texas | 78759 | — |
| Suzanne Bruce and Associates, P.A.,The Center for Skin Research | Houston | Texas | 77056 | — |
| Virginia Clinical Research Inc | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01475955, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2016 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01475955 live on ClinicalTrials.gov.